206 related articles for article (PubMed ID: 15999537)
21. Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents.
Chen Y; Liu HR; Liu HS; Cheng M; Xia P; Qian K; Wu PC; Lai CY; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2012 Mar; 49():74-85. PubMed ID: 22265685
[TBL] [Abstract][Full Text] [Related]
22. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
23. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
24. Euphorbia Species-derived Diterpenes and Coumarins as Multidrug Resistance Modulators in Human Colon Carcinoma Cells.
Wiśniewski J; Wesołowska O; Środa-Pomianek K; Paprocka M; Bielawska-Pohl A; Krawczenko A; Duarte N; Ferreira MJ; Duś D; Michalak K
Anticancer Res; 2016 May; 36(5):2259-64. PubMed ID: 27127131
[TBL] [Abstract][Full Text] [Related]
25. Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells.
Xiong J; Taniguchi M; Kashiwada Y; Sekiya M; Yamagishi T; Takaishi Y
Bioorg Med Chem; 2010 Apr; 18(8):2964-75. PubMed ID: 20363142
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
Tao H; Hwang I; Boger DL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and evaluation of naphthalene-2-carboxamides as reversal agents in MDR cancer.
Lokhande TN; Viswanathan CL; Joshi A; Juvekar A
Bioorg Med Chem; 2006 Sep; 14(17):6022-6. PubMed ID: 16730993
[TBL] [Abstract][Full Text] [Related]
28. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
29. Coumarin derivatives from Gerbera saxatilis.
Qiang Y; Chen YJ; Li Y; Zhao J; Gao K
Planta Med; 2011 Jan; 77(2):175-8. PubMed ID: 20669089
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.
Sun B; Yuan HQ; Xi GM; Ma YD; Lou HX
Bioorg Med Chem; 2009 Jul; 17(14):4981-9. PubMed ID: 19540127
[TBL] [Abstract][Full Text] [Related]
31. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
[TBL] [Abstract][Full Text] [Related]
32. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.
Baráth Z; Radics R; Spengler G; Ocsovszki I; Kawase M; Motohashi N; Shirataki Y; Shah A; Molnár J
In Vivo; 2006; 20(5):645-9. PubMed ID: 17091772
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
[TBL] [Abstract][Full Text] [Related]
35. Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.
Jiménez-Alonso S; Pérez-Lomas AL; Estévez-Braun A; Muñoz Martinez F; Chávez Orellana H; Ravelo AG; Gamarro F; Castanys S; López M
J Med Chem; 2008 Nov; 51(22):7132-43. PubMed ID: 18954040
[TBL] [Abstract][Full Text] [Related]
36. Novel multidrug-resistance modulators, KR-30026 and KR-30031, in cancer cells.
Choi SU; Lee BH; Kim KH; Choi EJ; Park SH; Shin HS; Yoo SE; Jung NP; Lee CO
Anticancer Res; 1997; 17(6D):4577-82. PubMed ID: 9494571
[TBL] [Abstract][Full Text] [Related]
37. Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.
Biscardi M; Teodori E; Caporale R; Budriesi R; Balestri F; Scappini B; Gavazzi S; Grossi A
Leuk Res; 2006 Jan; 30(1):1-8. PubMed ID: 16061283
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein.
Raad I; Terreux R; Richomme P; Matera EL; Dumontet C; Raynaud J; Guilet D
Bioorg Med Chem; 2006 Oct; 14(20):6979-87. PubMed ID: 16824763
[TBL] [Abstract][Full Text] [Related]
39. 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.
Shah A; Naliapara Y; Sureja D; Motohashi N; Kawase M; Miskolci C; Szabo D; Molnár J
Anticancer Res; 1998; 18(4C):3001-4. PubMed ID: 9713499
[TBL] [Abstract][Full Text] [Related]
40. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities.
Mehdipour AR; Javidnia K; Hemmateenejad B; Amirghofran Z; Miri R
Chem Biol Drug Des; 2007 Oct; 70(4):337-46. PubMed ID: 17937779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
